Authors are requested to submit a covering letter indicating that their manuscript represents original unpublished material that has not been and will not be published elsewhere (if accepted). This restriction does not apply to results published as abstracts of communications, letters to the editor or as preliminary reports. By submitting a manuscript the authors warrant that they have obtained permission to use any copyrighted or previously published materials.
The submission of a manuscript by authors implies that they automatically agree to assign exclusive copyright to the journals if the manuscript is accepted for publication. The work should not be published elsewhere in any form without the written permission of the journals. All rights of the articles published in the journals are reserved. No part of this publication may be reproduced, translated or transmitted in any form or by any means (electronic, mechanical or otherwise) without permission from the journals.
Conflict of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.
Human experiments should be performed only in accordance with the ethical standards provided by the responsible committee of the institution and in accordance with the Declaration of Helsinki (as revised in Edinburgh 2000), available at http:// www.wma.net/e/policy/b3.htm. Animal experiments should be in accordance with the instructions for the care and use provided by the institution at which the research was carried out.
All investigations on human subjects must include a statement that the subject gave informed consent. Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used).
All authors should have participated sufficiently in the work to take public responsibility for the content. Written approval signed by all authors should be presented with the manuscript. The sequence of author's names represents the degree of contribution. Co-authorship should be indentified in the manuscript.
The manuscript should be submitted online through EVISE® online submission system or emails to each Editorial Office. Either method is applicable to submit manuscripts. Repeated submission is not necessary, and EVISE® online submission is recommended. The text should be double spaced and have wide margins. The manuscript should be arranged in the following order: 1) Title Page, 2) Keywords, 3) Abstract, 4) Corresponding author, 5) Introduction, 6) Materials and Methods, 7) Results, 8) Discussion, 9) Acknowledgments, 10) References, 11) Tables, 12) Figure Legends, and 13) Figures. Please indicate the page of your manuscripts to facilitate reviewing.
Short communications not exceeding two printed pages, including title, author affiliations, references, and one figure or table, are acceptable for rapid publication if requested by the authors.
Letter to editor with criticisms or comments of less than 500 words and five references are welcome. Preference is given to letters related to articles published in the journals.
The title page should contain, on separate lines, the title of the manuscript, a running title of no more than 40 letters, the name(s) and affiliation(s) of the author(s), and the mailing address, telephone and fax numbers, and Email address of the corresponding author. The title must be informative, specific, and concise. Serialization of articles into parts is not permitted; such articles may be submitted independently with self-sufficient titles.
Keywords and Abstract
Provide 3-10 key words or phrases for indexing purposes, using terms from the latest US National Library of Medicine's Medical Subject Headings (MeSH) browser list at (http://www.nlm.nih.gov/mesh/meshhome.html). If appropriate MeSH terms are not available, other suitable terms may be used. Full-length submissions should include an abstract of up to 250 words in structured form, consisting of an Objective, Methods, Results, and Conclusion.
The text should include the following sections. The Introduction summarizes the rationale, provides a concise research background (not an exhaustive review) and states in one sentence the objective of the study. Do not include any results or the conclusions of the study. The Materials and Methods provide technical information about the study. Do not describe methodological details that have been published previously. Specifications (including the manufacturer, city, and the country) should be given for the main drugs, chemicals, and instruments. Indicate the statistical methods used and identify statistical significance using superscripts (a and b) following the data (a P < 0.05, b P<0.01) The Results are the findings, using SI units. In a sample, the number of effective digits is determined by the variation within the sample, that is, one-third of the standard deviation. Digits may be separated into groups of three by a small space. The Discussion deals with the interpretation of the results and their comparison with those of other studies. Do not repeat the results, do not review the literature, do not repeat textbook knowledge and do not cite references that do not have a close relationship with the present results. End with a brief conclusion linking back to the aim of the study.
The use of abbreviations, except for units of measure, is discouraged. At the first appearance in the abstract and the text, abbreviations should be preceded by words for which they stand.
Tables must be concise and cited consecutively using Arabic numerals in the text (Table 1, Table 2, etc.). Each table should be typed on a separate sheet. The title of the table should clearly indicate the nature of the contents and sufficient details should be included in the footnote to facilitate interpretation without reference to the text. Use horizontal rules only.
Figures (photographs, drawings, diagrams and charts) should be clear, easily legible and cited consecutively using Arabic numerals in the text (Figure 1, Figure 2, etc.). Please supply figures 1.5 to 2 times the size at which they will be finally reproduced. For line work, submit black-ink drawings of professional quality. Micrographs or other glossy photographs must be of the highest quality. If a figure comprises more than one glossy photograph, these should be marked A, B, C, etc. Figure legends should be marked clearly with the correspond letter. Legends should contain sufficient details to permit figure interpretation without reference to the text. Scale markers should be indicated in the photographs. Color plates are also welcome. The choice of cover art illustration will be made by the Editor.
The Journal advocates the citation of new papers; old references are better replaced with updated ones. The authors are responsible for the correctness of references. References are numbered consecutively in the order in which they appear in the text. Citation should be labeled in superscript parenthesis and should appear in front of the period or comma at the end of the sentence/clause. All references should be cited. Unpublished data, personal communications, abstracts at meetings and manuscripts submitted for publication are not acceptable as references. Information from such sources may be cited in the text with the sources given in parentheses. References should be listed in numerical order in the Reference section. Journal titles should be abbreviated according to the list of Journals Indexed in Index Medicus or MEDLINE (www.nlm.nih.gov). Please note that no periods are used after the authors-initials or journal abbreviations. A period is used at the end of each reference. The type and punctuation of references is consistent with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals of the International Committee of Medical Journal Editors (http://www.ICMJE.org). Some examples are as follows:
Journal article up to six authors (list all authors)
Prasad TNVKV, Elumalai EK. Biofabrication of Ag nanoparticles using Moringa oleifera leaf extract and their antimicrobial activity. Asian Pac J Trop Biomed 2011; 1(6): 439-42.
Journal article more than six authors (list first six and add et al.)
Namiduru ES, Tarakçoglu M, Namiduru M, Kocabas R, Erbagci B, Meram I, et al. Increased serum nitric oxide and malondialdehyde levels in patients with acute intestinal amebiasis. Asian Pac J Trop Biomed 2011; 1(6): 478-81.
Waugh N, Royle P, Craigie I, Ho V, Pandit L, Ewings P, et al. Screening for cystic fibrosis-related diabetes: a systematic review. Southampton (UK): NIHR Evaluation, Trials and Studies Coordinating Centre (UK); 2012, p. 15-8.
Chapter in a book:
Cubler DJ. Dengue/Dengue haemorrhagic fever: history and current status, in new treatment strategies for dengue and other flaviviral diseases. In: Bock G, Goode J, editors. Novartis foundation symposium 277. Chichester: John Wiley & Sons, Ltd; 2008.
Authors should obtain written permission for everyone acknowledged by name, since readers may infer their endorsement of the paper and its conclusions.
For more information on writing for Hainan Medical University Journal Publisherfamily of journals see the following links.
Guide for authors of
Asian Pacific Journal of Tropical Medicine
Asian Pacific Journal of Tropical Biomedicine
Asian Pacific Journal of Reproduction
Journal of Acute Disease
Journal of Hainan Medical University (English)
Journal of Hainan Medical University (Chinese)
Asian Pacific Journal of Tropical Disease
Journal of Coastal Life Medicine
Committee on Publication Ethics (COPE): Journals published by Hainan Medical University Journal Publisher follow the COPE Code of Conduct